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Abstract 
Introduction 
The most common cause for HIV infection in children in developing countries is the vertical 
transmission of HIV from mother to child. Without any intervention the vertical transmission 
rate from mother to child will be between 15-50%, depending on a number of factors. An 
effective prevention of mother-to-child transmission (PMTCT) program can dramatically 
reduce this transmission rate to as low as 2-5%. There appears to be a gap between PMTCT 
policy guidelines and actual implementation, and while the reasons for this are multi-
factorial, one facet may be local shortfalls in the program.  
Aim: To review the implementation of the PMTCT program in the George sub-district for 
2010.  
Objectives: To assess whether the PMTCT program is being conducted according to 
established provincial protocol; to describe possible local shortfalls in the PMTCT program; 
to make recommendations to improve the identified shortfalls.  
Methods 
A retrospective descriptive study, based on a record review of patient files, the PMTCT 
register, and birth registers in the labour ward of George provincial hospital. Every HIV 
positive pregnant woman from the George sub-district who delivered at the George provincial 
hospital obstetric unit during 2010 was included. Missing files and medical records were 
excluded. Data was collected from each record in the registers according to set criteria, and 
entered into a Microsoft Excel data sheet. 
Results 
95% of women in the study had an HIV test at the clinic, and 93% had a CD4 count. This 
shows good initial uptake and acceptance of the program. However, 28% did not receive 
adequate antenatal PMTCT cover, 33% of patients who required highly active antiretroviral 
treatment (HAART) did not receive it, and 34% of women did not receive adequate PMTCT 
cover during labour. 86% of babies received their initial PMTCT medication within 72 hours 
of birth. The one month zidovudine treatment for babies (before October 2010) and six weeks 
nevirapine treatment (after October 2010) was not documented in 30% and 74% of cases 
respectively.  
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Discussion 
While many aspects of the PMTCT program are being well applied in the George sub-
district, there are significant shortfalls in the implementation of the program. These need to 
be addressed to ensure optimal prevention of HIV transmission from mother to child. 
Particular points which need to be focused on are improved record keeping, increasing the 
percentage of HIV positive women receiving adequate antenatal and intrapartum PMTCT, 
and increasing the percentage of HIV positive women receiving HAART. 
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Introduction 
 
The HIV epidemic continues to be a key public health issue worldwide.
1
 The prevention of 
mother-to-child transmission (PMTCT) of HIV remains one of the most vital aspects of HIV 
prevention, and is at the forefront in the campaign against this epidemic.
2 
The PMTCT 
program forms part of the key priority areas of The HIV and AIDS and STI Strategic Plan for 
South Africa 2007-2011 
3
. It is also in line with the World Health Organisation (WHO) 
PMTCT strategic vision 2010-2015 
2
 and the United Nations’ Millennium Development 
Goals 4-6 to reduce child mortality, improve maternal health, and halt and begin to reverse 
the spread of HIV by 2015.
4
 According to the WHO PMTCT strategic vision 2010-2015 
2
  
the number of pregnant women in South Africa living with HIV is over 200 000, with 
approximately 72% receiving antiretrovirals (ARVs) to reduce the risk of mother-to-child 
transmission of HIV. 
 
The prevalence of HIV positive mothers attending antenatal clinics in the public sector in the 
Western Cape was estimated to be 15.1% in 2006 and 16.1% in 2008 according to The 2008 
National Antenatal Sentinel HIV and Syphilis Prevalence Survey.
5 
The prevalence of HIV 
positive mothers in the George sub-district of the Western Cape was 14% in 2008 and 15.4 % 
in 2009 (unpublished data, personal communication Dr Nel, head of department of 
Obstetrics, George Hospital). 
 
It is well established that the most common (>90%) cause for HIV infection in children in 
developing countries is the vertical transmission from mother to child.
2,6. 
Without any 
intervention the vertical transmission rate from mother to child will be between 15-50%, 
depending on a number of factors.
2,7-10 
This transmission rate can be radically reduced by an 
effective PMTCT program, which includes ARV chemoprophylaxis and feeding advice, with 
or without feeding replacement scheme. 
2,10,11
 In patients on dual ARV chemoprophylaxis 
transmission is less than 2% in non-breastfeeding populations and less than 5% in 
breastfeeding populations. 
2,11,12
 Additionally, it has been proven that highly active 
antiretroviral treatment (HAART) should be given to those pregnant women who need it for 
their own health.
6, 13 
This has reduced transmission rates in first world countries to 0.99%.
12 
 
A highly controversial aspect of PMTCT is the choice of infant feeding, and is often the 
weakest aspect in the PMTCT counselling.
14
 Transmission of HIV from mother to child 
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through breast milk ingestion contributes a significant proportion of HIV infections.
9,13 
It is 
therefore a logical progression that exclusive formula feeding reduces the risk of HIV 
transmission (to as low as 4% in some studies compared to 16% in exclusive breastfeeding 
group
15
). However, the benefit of exclusive formula feeding is possibly outweighed by the 
risk of malnutrition and contracting other infectious diseases (diarrhoea and respiratory 
illnesses), and the risk of it not being properly prepared. Therefore while the WHO had 
previously encouraged formula feeding where it was acceptable, affordable, feasible, safe and 
sustainable,
16
 they now advocate breastfeeding (with ARV coverage) above formula feeding, 
in their latest recommendations.
17 
 
If the PMTCT program is optimally implemented it should prevent many children from being 
burdened with the morbidity and mortality associated with HIV/AIDS,
8
 and by advocating 
appropriate introduction of HAART it will improve maternal survival. The positive outcomes 
not only include saving lives, but also reduced morbidity and health expenditure. 
 
While evidence proves that implementation of PMTCT is expanding and progressing, there is 
still much room for improvement.
1
 There are many potential barriers which exist to prevent 
successful PMTCT programs and all of these need to be addressed to ensure a successful 
outcome.
13,14,18-21 
These barriers include health system barriers:  delay in various aspects of 
service delivery in the care continuum, health care and counselling staff shortages, supply 
shortages, impaired health access due to clinic quota systems, staff not adequately trained, 
poor integration of ANC and HIV services. Patient centered barriers include: fear of stigma 
and community isolation, lack of partner and community support, non-disclosure of HIV 
status, mental health issues, economic constraints, cultural issues, language barriers, 
incomplete understanding of their disease and treatment regimes. 
 
Work done in KwaZulu-Natal, South Africa, showed promising results in implementation of 
the PMTCT program, but identified particular local barriers to a successful program.
22
 These 
barriers included long waiting times for pre and post test counselling, and in the counselling 
sessions preparing patients for the HAART program as well as a delay in receiving CD4 
results, leading to a delay in referral to HAART clinic. One study showed only 76% of 
women attending an antenatal care (ANC) clinic had an HIV test.
23 
Another study showed 
that 66% and 88% of HIV positive women received antenatal zidovudine (AZT), while 14% 
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and 10% were started on HAART, and 14% and 2% received no intervention.
18
 61% and 
86% reported adherence to PMTCT medication.
18 
 In Cape Town, 73% of HIV positive pregnant women were started on HAART, 20% 
received antenatal AZT and 8% had no intervention.
24
 A similar study in Cape Town showed 
that 77% of HIV positive women received PMTCT intervention, but 33% had less than four 
weeks of antenatal AZT coverage while 3% received no intervention.
 25
 
In Soweto, South Africa, 93% attended an ANC clinic, while 7% were unbooked. 51% had 
CD4 counts greater than 200, while 22% had CD4 counts lower than 200, and 27% of CD4 
counts were unknown.
20 
60% of the women requiring HAART did not receive it. 31% of 
infants received inadequate PMTCT regimes, and 4% received no treatment at all. 84% of 
women chose to formula feed.
20
 
In Johannesburg, 6% of women were unbooked.
26
 Babies born before arrival (BBA) to a 
delivery unit was the commonest cause for not receiving PMTCT treatment in labour. More 
than 95% of infants received PMTCT medication. 60% of the HIV positive women chose to 
formula feed, while 38% did not have their choice documented, and only 1.3% of women 
chose to breastfeed.
26
 
 
The evidence suggests that opportunities are being missed in providing optimal PMTCT care. 
While the reasons for this are multi-factorial, one facet may be due to local shortfalls in the 
program.  
 
While working in Obstetrics at George provincial hospital, the researcher noticed that some 
HIV positive patients were not receiving adequate antenatal and intra-partum PMTCT 
coverage. The Researcher discussed this with both the head of department and the head of 
nursing of obstetrics and gynaecology. Together it was decided that this would be an 
important area of study. 
 
Aim: To review the implementation of the PMTCT program in the George sub-district for the 
year 2010.  
 
Objectives: To assess whether the PMTCT program is being conducted according to 
established provincial protocol, to describe possible local shortfalls in the PMTCT program, 
and to make recommendations to improve the identified shortfalls.  
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Methods 
 
Setting: 
 
Maternity ward, George provincial hospital, George sub-district, Western Cape. 
George Municipality population figures amounted to 136 540 people in 2007 according to 
Stats SA. According to the Municipality the population was estimated at ±190 000 in 2009. 
The population is diversified across race groups and cultures and is characterised by varying 
levels of socio-economic status and levels of education. 
 
To serve this population there are a number of health facilities. There is one level 2 hospital, 
namely George Provincial hospital. There are no district hospitals, and no mobile obstetric 
units (MOU’s). There are a total of 14 primary health care (PHC) facilities: seven clinics, 
four mobile clinic units, two community health centres and one satellite clinic. The total 
antenatal visit for these clinics during 2010 were 11 275, of which 2719 (24%) occurred at 
Thembalethu clinic. Antenatal care and PMTCT is offered at all of these PHC facilities, but 
HAART is only available at two sites. There is also one private hospital. 
 
The 2009 Policy and Guidelines for the Prevention of Mother-to-Child Transmission of HIV, 
of the Department of Health of the Western Cape were being used in the George sub-district 
in 2010.
27
 A revision of these guidelines occurred in 2010, but was only implemented in 
October 2010, as stated in a Western Cape Department of Health circular no. 147/2010. 
The specific variables in the PMTCT program which were focused on in this study include: 
 Did the patient have an HIV test (Voluntary Counselling and Testing (VCT))? 
 Did the patient have a CD4 count? 
 Did the patient receive adequate antenatal PMTCT drugs according to the protocol? 
 If appropriate was HAART started? 
 Did the patient receive adequate PMTCT medication during labour? 
 Did the baby receive PMTCT medication? 
 Was the mother counselled about choice of feeding method? 
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The revised Western Cape Provincial PMTCT guidelines for 2010, implemented from 
October 2010 did not influence these variables, due to the broadness of the stated variables. 
The fact that the 2009 guidelines were amended has been allowed for in the data collection. 
 
Study design: 
A retrospective descriptive study, based on a record review of patient files and the PMTCT 
and birth registers. 
 
Study population:  
Every HIV positive pregnant woman from the George sub-district who delivered at the 
George Provincial Hospital Obstetric unit during 2010. 
 
Study sample:   
All HIV positive patients from the George sub-district who were entered in the birth register 
during 2010. 
Sample size: 410 patients  
 
Inclusion criteria:  
Every HIV positive pregnant woman from the George sub-district, who delivered at the 
George Provincial Hospital Obstetric unit during 2010. 
 
Exclusion criteria:  
Patients from areas outside the George sub-district, who were referred to George Provincial 
Hospital. Patients where files and medical records were missing were also excluded. 
  
Data collection 
For each patient entry data was taken from the birth register, the PMTCT register and the 
patient’s medical records. This data was assessed according to the chosen variables in the 
PMTCT program (see appendix A) and entered into a predesigned data capturing sheet in MS 
Excel (see appendix B). 
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The data was checked manually and prepared for analysis by the researcher. After all data 
was checked the file numbers were removed from the data sheet to remove any identifying 
factors and so ensure patient confidentiality. 
 
Analysis 
STATISTICA version 10 was used to analyse the data. The primary nature of the project was 
descriptive.  As such, descriptive techniques were used to address the primary objectives of 
the study.  Most of the collected data was binary (categorical data) and as such frequency 
counts and proportions are presented.  All data is visually presented using histograms, bar 
charts and pie charts.  
 
Ethical aspects 
 
Ethics approval was obtained from the University of Stellenbosch Ethics Committee, 
reference N11/07/213. Permission for the study was obtained from the Western Cape 
Department of Health, reference RP 130/2011. 
Data was obtained from hospital registers and files. Patient names were not reflected in the 
data collection or analysis and were only used to draw patient files. Patient file numbers were 
removed from the data sheet once data capturing was complete, to remove any identifying 
factors. This ensured anonymity and respect for each person’s confidentiality.  
A waiver of informed consent was granted for these reasons. 
 
Results 
433 HIV positive patients were identified from the labour ward birth register and the PMTCT 
register. 13 of these patients were excluded because they were referred in from outlying 
district hospitals. A further 10 patients were excluded as their files and adequate 
documentation could not be found, due to filing errors. This left a total of 410 eligible patient 
entries. 
 
The mean age was 26.7 years, with the minimum age 13 years and the maximum 43 years. 
The age groups 20-30 years made up 61%. The mean parity (number of children excluding 
the current pregnancy) was one, with a maximum parity of six. More than 78% delivered at 
Stellenbosch University  https://scholar.sun.ac.za
11 
 
term. 158 (39%) of women delivered between 36-38 weeks gestation, 150 (37%) between 38 
to 40 weeks, and 14 (3%) delivered between 40 and 42 weeks of gestation. 111 (27%) had 
caesarean sections, while 299 (73%) delivered vaginally. 390 (95%) women had an HIV test 
and 381 (93%) had a CD4 count done at the clinic. 
 
289 (70%) of HIV positive pregnant women were from Thembalethu residential area. (See 
fig. 1.)  
 
Fig.1 Patients according to residential areas (n=410). 
 
Thembalethu clinic was attended by 229 (56%) of HIV positive pregnant women. The clinic 
with the second highest number of attendees was Lawaaikamp with 37 (9%) (See fig. 2). 
 
Fig.2 Patients according to clinics attended (n=410). 
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Figure 3 shows the distribution of the CD4 results. The majority of CD4 counts were in the 
200-400 range. 
 
Fig.3 Distribution of CD4 counts 
 
Of 410 women, 162 (40%) qualified for HAART according to the protocol. Of those 
requiring HAART 85 (52%) received HAART, while 53 (33%) did not receive it, and in 24 
(15%) of cases it was not documented if HAART was started or not (See fig. 4). Four of the 
85 women who were started on HAART defaulted treatment. 
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Fig.4 HAART started in those that qualified (n=162).  
 
293 (71.5%) of the women received adequate antenatal PMTCT cover, while 114 (27.8%) did 
not. (See fig. 5). 
 
  
Fig. 5 Adequate antenatal PMTCT cover (n=410). 
Figure 6 describes the reasons for inadequate antenatal PMTCT treatment. 43 (38%) had 
treatment interrupted usually by missing clinic appointments. 25 (22%) had insufficient 
PMTCT cover as they did not receive at least four weeks of continuous treatment. 17 (15%) 
were poor clinic attendees, and a further 17 (15%) were unbooked and therefore missed the 
opportunity to be started on PMTCT treatment. 
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Fig. 6 Reason for inadequate antenatal PMTCT treatment (n=114). 
226 (55%) women received adequate PMTCT cover in labour, while 139 (34%) women did 
not. In 45 (11%) women it was unknown if they received PMTCT treatment during labour 
due to insufficient documentation. (See fig. 7). 
  
Fig.7 Received adequate PMTCT treatment during labour (n=410). 
Figure 8 shows reasons for inadequate PMTCT treatment during labour. 54 (38.6%) of the 
139 women who had inadequate treatment, received their treatment, but it was too late (less 
than two hours before delivery) to be effective. 28 (20%) women’s babies were born before 
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arrival (BBA) at the hospital; and 24 (17.1%) women arrived at the hospital fully dilated with 
imminent delivery, and so medication was not given. (These women all delivered within 5-30 
minutes of arrival at hospital). 19 (13.6%) women were given treatment, but it was 
interrupted, this means that while single doses were given, health care workers did not follow 
the protocol of three hourly AZT during active labour, and doses were missed, or unduly 
delayed. Delays of an hour or more were seen as significant. One patient was intubated and 
ventilated in ICU, and gave birth unexpectedly, before any PMTCT medication could be 
given. When intra-uterine deaths (IUD’s) or miscarriages were diagnosed, medication was 
not needed and therefore not given, as seen in five (3.6%) of the 139 women. 
 
Fig. 8 Reason for inadequate PMTCT treatment in labour (n=139). 
Of the 410 mother-infant pairs, 353 (86%) of the babies received their initial PMTCT 
medication within 72 hours of birth. In 11 (3%) cases the medication was not applicable, due 
to infant demise. In 42 (10%) cases it was not documented if medication was received or not, 
and four (1%) cases did not receive medication at all. (See fig. 9). 
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Fig. 9 Baby received initial PMTCT medication within 72 hours (n=410). 
 
The treatment of the baby after the 72hours is where the protocol change most significantly 
affected the study. The protocol in use before October 2010 stated that if the mother had 
received adequate antenatal (at least four continuous weeks of PMTCT) and intra-partum 
PMTCT coverage, then short course (one week) of AZT was given to the baby. However if 
the mother had received inadequate PMTCT coverage, then the baby received long course 
(one month) of AZT. After October 2010 all babies received six weeks of NVP on discharge 
from hospital. (See Appendix C) 
  
The one month of AZT group comprised 308 of the 410 babies. In 151 (49%) cases the one 
month of treatment was not applicable, this was either due to infant demise (2.5%), or due to 
the fact that they did not qualify for the long course treatment according to the protocol. 
These babies then received the short course (one week) of AZT. 64 (21%) of the 308 babies 
were documented to have received their long course PMTCT medication. In 93 (30%) cases 
it was not documented if medication was given. (See fig. 10). 
 
The six week NVP group comprised 102 babies. In two (2%) cases the medication was not 
applicable due to infant demise. 24 (24%) of the babies from this group were documented to 
have received their PMTCT medication, while in 76 (74%) it was not documented if they 
received their medication or not. (See fig. 11). 
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Fig. 10 Baby received one month of AZT  Fig.11 Baby received six weeks of NVP 
Before October 2010 (n= 308).   After October 2010 (n=102). 
 
In total, 392 (96%) were counseled with regards to infant feeding options; in ten (2%) 
counselling was seen as not applicable due to infant demise, while in a further eight (2%) 
counseling was not documented. (See fig. 12). 
 
 
Fig. 12 Counseled with regards to infant feeding (n=410). 
Stellenbosch University  https://scholar.sun.ac.za
18 
 
341 (83%) mothers chose to exclusively formula feed, 38 (9%) chose to exclusively breast 
feed. Two babies (1%) had documented mixed feeds in the ward. In eight (2%) cases the 
feeding choice was not documented. Nine (2%) chose pasteurised expressed breast milk 
(PEBM) and two (1%) chose donated expressed breast milk (DEBM) (from an HIV negative 
donor). In ten (2%) cases feeding choice was not applicable due to infant demise. (See fig. 
13). 
 
 
Fig. 13 Chosen feeding method (n=410). 
 
 
Discussion  
The majority (70%) of patients in the study lived in the Thembalethu residential area, in 
George. Of the 14 PHC facilities, Thembalethu clinic had the highest HIV ANC case load, 
being attended by 56% of the sample, meaning this one clinic carried the majority of the case 
load. The clinic with the second highest number of HIV ANC attendees was Lawaaikamp 
(9%). The reason behind this higher case load may be due to a higher prevalence of HIV in 
Thembalethu, or that the population served by Thembalethu clinic may be larger than other 
clinics. Overall, Thembalethu clinic serviced 24% (2719) of the total ANC visits (11275) for 
all the clinics during 2010. More research is needed to understand this finding. 
There was a discrepancy between the number of patients who resided in Thembalethu area 
289(70%), and those who attended Thembalethu clinic 229(56%). There could be a number 
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of reasons for this, for example access difficulties, saturated daily patient quotas and HIV 
disclosure issues. More research is needed in this area. 
95% of women had an HIV test at the clinic and 93% had a CD4 count. This shows good 
initial uptake and acceptance of the program, compared to other South African studies where 
only 76% had an HIV test
23
, 70% had a CD4 count
22
 and 27% of CD4 counts were 
unknown.
20
  
As the total number of deliveries at George provincial hospital for 2010 was 3074 the 
prevalence of HIV in the pregnant women delivering at George hospital was 13.6% for 2010. 
This is less than the Western Cape Provincial prevalence in 2006 (15.1%) and 2008 (16.1%).
5
 
 Only 52% of women requiring HAART were initiated on it and 33% never received it. This 
is poorer than other studies where 73% and 60% of women received HAART.
22, 24
 As this is 
the group which has the highest risk of transmitting HIV from mother to child due their low 
CD4 counts, this needs to be improved. One should aim for all women requiring HAART to 
receive it. Possible reasons for this poor performance may be poor patient referrals between 
PHC clinics and HAART clinics, delay in the work-up and counselling sessions for HAART 
and patient attrition due to the inconvenience to patients of now having to attend two separate 
clinics. 
 
 Of the women, 293 (70.5%) received adequate antenatal PMTCT coverage, which is similar 
to other studies,
18
 but can still be improved upon. The reasons for not receiving adequate 
antenatal PMTCT coverage as found in this study include being unbooked, late booking and 
poor clinic attendance. The patient centered, community and health system issues underlying 
these reasons need to be explored in order to create solutions to improve antenatal PMTCT 
coverage. 
 
During labour, only 55% of women received adequate PMTCT cover, which is not 
satisfactory and should be markedly improved upon. The reasons for not receiving adequate 
intrapartum PMTCT coverage as found in this study include the baby being born before 
arrival at hospital, the mother receiving the medication too late, and the mother arriving at 
hospital with imminent delivery. The patient centered, community and health system issues 
underlying these reasons need to be explored in order to create solutions to improve 
intrapartum PMTCT coverage. 
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86% of the babies received their initial PMTCT medication within 72 hours of birth. This 
compares favourably with 92% in other work in South Africa.
22 
 
With regards the one month AZT (protocol in use before October 2010) and six weeks NVP 
(protocol in use after October 2010) in 30% and 74% of cases respectively it was not 
documented if the child received the medication or not, which is unacceptably high. There 
seems to be an assumption made by health care personnel that because an instruction is 
written in the protocol, it is automatically followed, and that documenting the execution is not 
needed. Doctors do not consistently prescribe the PMTCT medication on the patient’s 
treatment chart (possibly because they assume the nurses will give the treatment). Nurses do 
not consistently document in their notes that the treatment has been given (possibly because 
they assume that it is standard practice that the medication is given appropriately). This lack 
of consistent documentation not only makes reviewing the PMTCT program difficult, it also 
obscures whether protocol is being followed or not.  
96% of women were counseled about infant feeding choices.   83% chose to formula feed, 
and 9% chose to breastfeed, which is similar to other studies where 84% chose formula 
feeding.
20
 The latest WHO guidelines recommend that women should be breastfeeding, with 
ARV coverage.
17
  
 
Limitations of the study 
This was a relatively small, retrospective descriptive study and may not be generalisable to 
the general population, although the intention was to address local shortfalls. 
 
While this study aimed to assess the implementation of the PMTCT program in the George 
sub-district, the information was accessed at hospital level, introducing bias towards 
institutional interpretation and giving a reduced community perspective. The obstetric service 
in the George sub-district is heavily hospital based, as there is no MOU. This limits our 
understanding of what occurs at the pre-hospital, community level. 
 
 The 2009 Policy and Guidelines for the Prevention of Mother-to-Child Transmission of HIV, 
of the Department of Health of the Western Cape were being used in the George sub-district 
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in 2010.
27
 A revision of these guidelines occurred in 2010, but was only implemented in 
October 2010. See appendix C for a summary of the main changes. The criteria evaluated in 
this study were broad, and so this allowed the change in guidelines to be absorbed. What was 
evaluated was if the treatment was given according to protocol, not which protocol was used, 
and so when protocol changed, all that happened was that adherence to the new protocol was 
checked and evaluated.  
Only those patients who delivered at George Provincial hospital were included in the study. 
Patients who delivered at home or in the private sector were missed. 
Ten files were lost or misplaced, limiting the number of patient entries. 
 
Recommendations: 
The following recommendations are made on the basis of the findings of this study: 
 Set up a discussion forum to meet with nursing staff, clinical managers, and senior 
clinicians to discuss the findings of this study. 
 Disseminate the study findings to the community using the community health forum 
 The capacity of Thembalethu clinic needs to be increased, in the form of staffing, 
clinic hours, ambulance support, or even a mobile obstetric unit.  
 Record keeping must be improved and consistent. 
 The percentage of HIV positive women receiving adequate antenatal and intrapartum 
PMTCT must be increased. 
 The percentage of HIV positive women receiving HAART must be increased. 
 Antenatal care and HIV care need to be more integrated.  
 There is a definite need to improve upon the PMTCT and HAART coverage of 
pregnant women and to monitor if improvement is occurring. This can be assessed by 
a follow up clinical audit or a quality improvement cycle.  
 Establishing local targets for PMTCT and HAART coverage may be a useful tool to 
measure performance. 
 Mothers need to make informed decisions on their feeding choice. Health care 
providers need to have up to date knowledge of the safest feeding practices for HIV 
exposed babies. 
 An improved strategy is needed to ensure adherence to PMTCT medication. This 
includes improved or extended patient counseling and education, improved 
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community involvement, awareness and support, and using home-based carers to 
trace women who miss their ANC clinic appointments. 
 
Conclusion:  
This study reviewed the implementation of the PMTCT program in the George sub-district, in 
order to assess whether the PMTCT program was being conducted according to established 
provincial protocol, and so to describe possible local shortfalls in the PMTCT program, and 
to make recommendations to improve the identified shortfalls.  The key findings were: 
 
The majority of HIV positive pregnant women in the George sub-district attended the 
Thembalethu PHC clinic, which clearly carries a disproportional heavy caseload.  
 
Many aspects of the PMTCT program are being well applied, including high uptake of HIV 
and CD4 testing, initial PMTCT treatment to babies within 72 hours, as well as the 
counselling of mothers with regards infant feeding choices.  
 
However, opportunities are being missed in all aspects of the PMTCT care continuum. 
Particular points which need to be focused on are increasing the percentage of HIV positive 
women receiving adequate antenatal and intrapartum PMTCT, increasing the percentage of 
HIV positive women receiving HAART, and improved record keeping.  
 
The results of this study will be presented to the nursing staff, clinical managers, and senior 
clinicians, as well as disseminated to the community using the public health forum, as the 
shortfalls identified need to move the community and the health systems into urgent action to 
address these shortfalls. 
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Appendix A:  Chosen study variables and how they were evaluated.  
 
 Residential area 
 Clinic attended 
 Age in years. 
 Parity (number of children excluding the current pregnancy) 
 Did the patient have an HIV test in the antenatal period?  
Yes 
No 
Unknown - if it was not documented that an HIV test was performed, or if the ANC green 
card was not available to check if an HIV test was performed in the antenatal care period. 
 Did the patient have a CD4 count? 
Yes 
 No  
Unknown if it was not documented that a CD4 count was performed, or if the ANC green 
card was not available to check if a CD4 count was performed in the antenatal care 
period. 
 The actual CD4 count result was also captured where available 
 Did the patient receive adequate antenatal PMTCT drugs according to the protocol? 
Yes - if patient received at least four continuous weeks of antenatal AZT according to the 
protocol. Although the protocol requires AZT be started at 28 weeks of gestation, the 
minimum acceptable and effective length of treatment was considered to be four weeks, 
as it is documented as such in the PMTCT register. Four weeks was also used as the cut-
off, because if the mother received less than this, then according to the protocol the baby 
must then receive long course treatment with AZT (four weeks instead of  one week) in 
the neonatal period,  
No - if the patient did not receive a minimum of four continuous weeks of antenatal AZT. 
Unknown - if the antenatal clinic card does not document the information, or if the 
medical records could not be found. 
 Reasons for inadequate antenatal PMTCT: 
Interrupted – if there was an interruption in taking the medication, for any reason, 
defaulting treatment, missing clinic appointments, not having medication issued 
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Insufficient – if the patient did not receive the full four weeks of treatment. 
Unbooked - if never attended the clinic 
Late booker – if the patient’s first clinic visit (booking visit) occurred later than 28 weeks 
Preterm – if delivery occurred before a gestation of at least 37 weeks, thus resulting in 
insufficient time on antenatal PMTCT treatment. 
Poor clinic attendee – if the patient did not attend the clinic regularly to allow medication 
to be prescribed in a continuous manner. 
Unspecified - if no reason specific reason could be found for inadequate antenatal 
PMTCT 
 Was HAART started in those that qualified for it?  
Yes - if HAART was appropriately started (if CD4 count less than 250, or if clinically 
WHO stage 4) 
No - if HAART was NOT started despite a CD4 count less than 250 
Not needed – if the patient did not require HAART according to the protocol 
Unknown - if no CD4 count available to establish if HAART was needed, or if it was not 
documented if HAART was started. 
Those patients that were started on HAART, but then defaulted were also noted 
 Did the patient receive adequate PMTCT medication during labour? 
Yes - if patient received adequate PMTCT medication according to the protocol during 
labour. This included the initial stat doses of medication, given at least 2 hours before 
delivery, followed by 3hourly AZT, and in the new guidelines which were implemented 
in October, the stat dose of emtricitabine (FTC)+Tenofovir (TDF). ALL medications must 
have been given, and given TIMEOUSLY, to be evaluated as adequate. 
No - if the patient did not receive PMTCT medication according to the protocol during 
labour. 
Unknown - if it was not documented if the patient received medication. 
 Reasons for inadequate PMTCT during labour 
Late - if the medication was given, but not in time to be effective before delivery (a 
minimum of 2 hrs before delivery) 
Interrupted - if there was an interruption in the administration of the medication, so it was 
not given 3hrly as required. If the delay in 3hourly administration was less than an hour it 
was accepted as adequate. 
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Fully dilated - if the patient was already fully dilated and delivery was imminent at the 
time of admission, and there was no time for administration of medication. 
BBA - if the baby was born before arrival at the hospital, thus eliminating the opportunity 
to receive the PMTCT treatment during labour.  
IUD/miscarriage- if there was an identified intra-uterine death or miscarriage 
Unspecified, if there was no documentation in the patient’s file explaining why the 
required medication had not been given. 
Intubated and ventilated - where a patient was in a critical condition in ICU. 
 Gestational age - estimated duration of pregnancy either by dates or ultrasound expressed 
in weeks 
 Delivery type: 
NVD – when a baby was born by normal vaginal delivery 
C-section - when a baby was born by Caesarean section. 
 Delivery outcome: 
Live birth - if the baby was born alive 
Stillbirth or IUD - if the baby had demised prior to birth/miscarried 
BBA - if the baby was born prior to arrival at the George Provincial hospital 
 Did the baby receive PMTCT medication within 72hours of delivery? 
Yes - if the child received the medication 
No - if the child did not receive the medication 
N/A - if the child had demised. 
Not documented - if it was not documented in the patient’s file that the child received the 
medication. 
 Did the baby receive one month of AZT syrup (if required)( protocol in use before 
October 2010) or six weeks of NVP syrup (protocol in use after October 2010 )? 
Yes - if the child received the medication 
No - if the child did not receive the medication 
N/A - if the child did not require the medication according to the protocol, or if the child 
had demised. 
Not documented - if it was not documented in the patient’s file that the child received the 
medication. 
 Was the mother counselled about choice of feeding method? 
Yes - if the mother received counselling. 
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Not documented - if there is no documentation showing counselling or feeding choice 
N/A - if the baby had demised. 
 Chosen feeding method: 
Mixed feeding practices - if the staff documented mixed feeding practices in the ward. 
Not documented - if the staff did not document which feeding method the mother had 
chosen. 
Formula - if exclusive formula feeding is chosen and performed in the ward 
Breast feeding - if exclusive breast feeding is chosen and performed in the ward 
PEBM - if pasteurised expressed breast milk is chosen and performed in the ward 
DEBM - if donated expressed breast milk is chosen and performed in the ward 
Appendix B 
Excel data sheet – see separate attached document 
Appendix C 
Main changes in the PMTCT program from 2009 guideline to 2010 guideline 
  2009 Guidelines 2010 Guidelines 
Eligible for HAART if CD4 count <250 <350 
Preferred HAART regime AZT/d4T+3TC+NVP TDF+ 3TC/FTC+ NVP 
      
If not eligible for HAART:     
start AZT 300mg twice daily in the 
antenatal period from 28wks 14wks 
during labour single dose NVP+ AZT 3hrly 
single dose NVP+ AZT 
3hrly 
During or immediately after 
delivery --- 
TDF+FTC (combination 
tablet Truvada®) 
      
Infant regimes:     
If mother on HAART > 4wks Single dose NVP+  
NVP at birth, then daily 
for 6 weeks  
  AZT twice daily for 1 week 
irrespective of infant 
feeding choice 
If mother on AZT for PMTCT for 
>4wks Single dose NVP+ 
NVP at birth, then daily 
for 6 weeks and 
  AZT twice daily for 1 week 
continued as long as any 
breastfeeding 
If mother on HAART or AZT for 
PMTCT for <4wks Single dose NVP+ 
NVP at birth, then daily 
for 6 weeks and  
  AZT twice daily for 4 weeks 
continued as long as any 
breastfeeding 
If mother had no PMTCT treatment Single dose NVP+ 
NVP at birth, then daily 
for 6 weeks and  
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Abbreviations applicable to this table: 
3TC   Lamivudine 
d4T  Stavudine 
FTC   Emtricitabine 
TDF   Tenofovir 
 
 
  AZT twice daily for 4 weeks 
continued as long as any 
breastfeeding 
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